Develops diagnostic tests for gastrointestinal diseases.
Aug 2026Revenue $4.34M/yrExpenses $9.77M/yr
No trendCash runway ≈ 8 months from Aug 2026
Figures by year
When will Biomerica be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Aug 2026, revenue was $4.34M and expenses $9.77M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| May 2026 | $4.45M | $9.77M | −$5.32M |
| May 2025 | $5.31M | $10.4M | −$5.14M |
| May 2024 | $5.42M | $11.8M | −$6.37M |
| May 2023 | $5.34M | $12.6M | −$7.22M |
| May 2022 | $18.9M | $23.4M | −$4.53M |
| May 2021 | $7.20M | $14.7M | −$7.50M |
| May 2020 | $6.69M | $9.43M | −$2.74M |
| May 2019 | $5.20M | $7.61M | −$2.41M |
| May 2018 | $5.56M | $7.05M | −$1.48M |
| May 2017 | $5.79M | $6.75M | −$955K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.